ACIA
- NASDAQ - Telecom-Fiber Optics
Acacia Communications
|
$53.38 |
-0.54 -1.00%
|
$53.77
|
$57.53
|
-7.21% |
637,316 114.01%
|
559,000
|
Most Recent Note for ACIA - 2/27/2019 12:37:12 PM
Pulling back this week after bullish action on news earnings rose +52% on +24% sales revenues for the Dec '18 quarter. Prior 5 quarterly comparisons showed lower sales and earnings than the year ago periods. Went through a deep consolidation since noted with caution after it proposed a new Public Offering on 9/26/16, up from its $23 IPO on 5/13/16,
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BHBK
- NASDAQ - Banks-Northeast
Blue Hills Bancorp Inc
|
$24.58 |
+0.12
0.49%
|
$24.61
|
$25.80
|
-4.73% |
139,119 102.29%
|
136,000
|
Most Recent Note for BHBK - 2/27/2019 12:40:26 PM
Rebounded toward prior highs after slumping from its all-time high since its gap up on M&A news on 9/21/18. Reported very strong earnings increases in the Mar, Jun, Sep, and Dec '18 quarters above the +25% minimum guideline (C criteria).
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CCMP
- NASDAQ - CHEMICALS - Specialty Chemicals
Cabot Microelectronics
|
$113.87 |
+0.71
0.63%
|
$115.61
|
$123.76
|
-7.99% |
276,886 99.96%
|
277,000
|
Most Recent Note for CCMP - 2/27/2019 12:44:31 PM
Little resistance remains due to overhead supply up to the $123 level. Rebounding within striking distance of its all-time high with an impressive streak of 8 consecutive gains marked by volume. Reported earnings +60% on +58% sales revenues Dec '18 quarter, marking its 5th consecutive quarterly comparison above the +25% minimum earnings guideline (C criteria). Annual earnings history (A criteria) showed steady improvement since a downturn in FY '11-12 .
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CSGP
- NASDAQ - COMPUTER SOFTWARE & SERVICES - Business Software & Services
Costar Group Inc
|
$456.18 |
+49.65
12.21%
|
$463.33
|
$448.35
|
1.75% |
313,269 171.19%
|
183,000
|
Most Recent Note for CSGP - 2/27/2019 12:51:24 PM
Gapped up today and hit a new all-time high with a considerable volume-driven gain. Bullish action came after it reported earnings +125% on +24% sales revenues for the Dec '18 quarter, its 4th consecutive quarterly comparison above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history has been strong after a downturn in FY '15. Return On Equity at 11% is below the 17% guideline of the fact-based investment system. Completed a new Public Offering on 9/29/17.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DIOD
- NASDAQ - ELECTRONICS - Semiconductor - Integrated Cir
Diodes Incorporated
|
$40.37 |
-2.09 -4.92%
|
$41.64
|
$44.27
|
-8.81% |
512,768 136.74%
|
375,000
|
Most Recent Note for DIOD - 2/27/2019 12:53:01 PM
Gapped down today retreating after spiking to new all-time highs with impressive volume-driven gains. Noted in prior mid-day reports - "Reported greatly improved earnings increases in recent quarters through Dec '18 with strong sales revenues growth. Up and down annual earnings (A criteria) history remains a concern with regard to the fundamental guidelines of the fact-based investment system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DLHC
- NASDAQ - Comml Svcs-Staffing
D L H Holdings Corp
|
$6.45 |
+0.06
0.94%
|
$6.55
|
$6.54
|
-1.38% |
33,891 169.46%
|
20,000
|
Most Recent Note for DLHC - 2/27/2019 12:57:45 PM
Thinly-traded Commercial Services - Staffing firm is perched at its 52-week high following volume-driven gains. Recent quarterly earnings increases through Dec '18 were above the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) history is not a match with the fact-based investment system's guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DOC
- NYSE - HEALTH SERVICES - Home Health Care
Physicians Realty Trust
|
$17.75 |
-0.88 -4.72%
|
$18.57
|
$18.84
|
-5.79% |
1,390,640 114.08%
|
1,219,000
|
Most Recent Note for DOC - 2/27/2019 12:58:10 PM
This REIT's earnings increases in quarterly comparisons through Dec '18 have been below the +25% minimum guideline (C criteria) of the fact-based investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ENTG
- NASDAQ - ELECTRONICS - Semiconductor Equipment & Mate
Entegris Inc
|
$36.60 |
-1.13 -2.99%
|
$37.61
|
$40.17
|
-8.89% |
6,432,773 328.04%
|
1,961,000
|
Most Recent Note for ENTG - 2/27/2019 1:02:28 PM
Pulling back today with heavy volume after hitting a new all-time high on the prior session but reversing much of its early gain. Reported earnings +12% on +15% sales revenues for the Dec '18 quarter versus the year-ago period, its 2nd consecutive quarterly comparison below the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth has been strong and steady after a downturn in FY '12.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
FOXF
- NASDAQ - Leisure-Products
Fox Factory Holding Corp
|
$65.91 |
+4.78
7.82%
|
$69.87
|
$76.77
|
-14.15% |
461,552 160.26%
|
288,000
|
Most Recent Note for FOXF - 2/27/2019 1:05:57 PM
Reported earnings +53% on +29% sales revenues for the Dec '18 quarter, its 3rd quarterly earnings increase above the +25% minimum guideline (C criteria). Gapped up and rebounded toward its all-time high but erased much of its early gain. Faces resistance due to overhead supply up to the $76 level. Found support near its 200 DMA line during its choppy consolidation in recent months. Completed prior Secondary Offerings on 3/02/17, 11/18/16. 8/10/16, 3/11/16, and 7/11/14.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HEI
- NYSE - AEROSPACE/DEFENSE - Aerospace/Defense Products & Services
Heico Corp
|
$91.24 |
-2.36 -2.52%
|
$94.95
|
$95.00
|
-3.96% |
400,731 119.98%
|
334,000
|
Most Recent Note for HEI - 2/27/2019 1:07:45 PM
Reported earnings +26% on +15% sales revenues for the Jan '19 quarter. Prior quarterly comparisons versus the year ago periods have not been strong and steady above the +25% minimum earnings guideline (C criteria) of the fact-based investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HMI
- NYSE - Apparel-Clothing Mfg
Huami Corp Cl A Ads
|
$18.15 |
-0.69 -3.66%
|
$18.84
|
$19.09
|
-4.92% |
239,171 174.58%
|
137,000
|
Most Recent Note for HMI - 2/27/2019 1:10:19 PM
Perched at its 52-week high today following an impressive spurt of volume-driven gains. Prior mid-day reports noted - "Quarterly results through Sep '18 were strong, however, this Chinese - Apparel (wearable devices) firm has a limited history since its $11 IPO on 2/08/18."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HZNP
- NASDAQ - Medical-Biomed/Biotech
Horizon Pharma Inc
|
$22.03 |
+1.14
5.46%
|
$22.25
|
$24.03
|
-8.32% |
1,905,340 127.88%
|
1,490,000
|
Most Recent Note for HZNP - 2/27/2019 1:11:21 PM
Reported earnings +131% on +30% sales revenues for the Dec '18 quarter, its 2nd strong quarterly comparison versus the year ago period. Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system's fundamental guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
LLY
- NYSE - Medical-Diversified
Lilly Eli & Co
|
$125.97 |
+1.30
1.04%
|
$125.98
|
$125.16
|
0.65% |
16,572,066 213.70%
|
7,755,000
|
Most Recent Note for LLY - 2/27/2019 1:12:26 PM
Hitting new 52-week and all-time highs with yet another volume-driven gain today, adding to a recent spurt. Reported Dec '18 quarterly earnings +17% on +5% sales revenues, below the +25% minimum earnings guideline (C criteria) versus the year ago periods. Annual earnings (A criteria) have improved since a downturn in FY '14.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
LOW
- NYSE - RETAIL - Home Improvement Stores
Lowes Companies Inc
|
$106.33 |
+1.30
1.24%
|
$109.92
|
$117.70
|
-9.66% |
5,187,793 109.98%
|
4,717,000
|
Most Recent Note for LOW - 2/27/2019 1:14:05 PM
Reported earnings +8% on +1% sales revenues for the Jan '19 quarter. Prior comparisons were below the +25% minimum earnings guideline (C criteria) and its sub par sales revenues growth rate is not a match with the fact-based investment system's winning models.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MASI
- NASDAQ - HEALTH SERVICES - Medical Instruments &; Supplies
Masimo Corp
|
$134.49 |
+6.56
5.13%
|
$135.75
|
$130.40
|
3.14% |
463,843 110.97%
|
418,000
|
Most Recent Note for MASI - 2/27/2019 1:17:16 PM
Hitting new 52-week and all-time highs with today's big volume-driven gain. Reported +54% earnings on +7% sales revenues for the Dec '18 quarter, its 3rd consecutive quarterly comparison above the +25% minimum earnings guideline (C criteria). Sub par sales revenues growth rate leaves fundamental concerns.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NOVT
- NASDAQ - Elec-Scientific/Msrng
Novanta Inc
|
$80.06 |
+2.01
2.58%
|
$81.33
|
$80.11
|
-0.06% |
181,260 125.01%
|
145,000
|
Most Recent Note for NOVT - 2/27/2019 1:19:56 PM
Reported earnings +27% on +6% sales revenues for the Dec '18 quarter. Deceleration in its sales revenues growth rate is a concern, fundamentally. Made choppy progress since dropped from the Featured Stocks list on 10/05/18.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NTRI
- NASDAQ - Cosmetics/Personal Care
Nutrisystem Inc
|
$43.30 |
-0.22 -0.51%
|
$43.56
|
$45.25
|
-4.31% |
1,278,973 118.86%
|
1,076,000
|
Most Recent Note for NTRI - 2/27/2019 1:24:26 PM
Holding its ground in a tight range since gaping up on M&A news on 12/10/18. Reported Dec '18 quarterly earnings +45% on -1% sales revenues. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) and lacked sales revenues growth. Annual earnings (A criteria) have been improving after a considerable downturn in FY '11 and '12.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SERV
- NYSE - DIVERSIFIED SERVICES - Business/Management Services
ServiceMaster Global Holdings, Inc
|
$44.67 |
-0.59 -1.30%
|
$45.11
|
$46.15
|
-3.21% |
1,197,765 115.17%
|
1,040,000
|
Most Recent Note for SERV - 2/27/2019 1:37:16 PM
Gapped up on the prior session for a considerable volume-driven gain hitting new 52-week and all-time highs. Went through a deep consolidation below its 200 DMA line since last noted 11/06/18 after the spin-off of Frontdoor Inc (FTDR). Reported earnings +171% on +12% sales revenues for the Dec '18 quarter. Quarterly earnings increases through Sep '18 were below the +25% minimum guideline (C criteria) while sub par sales revenues increases were noted as a concern. Completed a Secondary Offering on 11/09/15. New CEO on 7/26/17.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TJX
- NYSE - RETAIL - Discount, Variety Stores
T J X Cos Inc
|
$50.97 |
+1.25
2.51%
|
$51.12
|
$56.64
|
-10.01% |
7,863,275 117.40%
|
6,698,000
|
Most Recent Note for TJX - 2/27/2019 1:37:57 PM
Reported Jan '19 earnings +10% on +2% sales revenues. Quarterly earnings history has not been strong and steady above the fact-based investment system's +25% minimum guideline (C criteria).
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
VEEV
- NYSE - Computer Sftwr-Medical
Veeva Systems Inc Cl A
|
$117.03 |
-2.70 -2.25%
|
$124.00
|
$122.73
|
-4.65% |
1,553,020 119.10%
|
1,304,000
|
Most Recent Note for VEEV - 2/27/2019 1:40:42 PM
Reported earnings +88% on +25% sales revenues for the Jan '19 quarter. Hit a new all-time high today but reversed into the red. Patient investors may watch for a pullback, new base, or secondary buy point to possibly develop and be noted in the weeks ahead. Made steady progress and stubbornly held its ground since noted in the 1/15/19 mid-day report - "Rebounded above its 50 DMA line with a streak of gains. Reported earnings rose +80% on +27 sales revenues for the Oct '18 quarter, marking its 3rd strong quarter with earnings above the +25% minimum guideline (C criteria). Progress has been choppy since dropped from the Featured Stocks list on 9/21/17."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|